Loading insider details...
Beta
Latest Form 4 (Apr 15, 2026): Grant/Award of 2,500,000 GERN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 15, 2026 | GERON CORP (GERN) | Grant/Award | 2,500,000 | n/a |
| Mar 4, 2026 | Vanda Pharmaceuticals Inc. (VNDA) | Sale | 42,434 | $350.8K |
| Feb 19, 2026 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 125,000 | n/a |
| Mar 4, 2025 | Vanda Pharmaceuticals Inc. (VNDA) | Tax Withholding | 26,941 | $128.2K |
| Feb 21, 2025 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 125,000 | n/a |
| Mar 6, 2024 | Vanda Pharmaceuticals Inc. (VNDA) | Sale | 8,147 | $35.9K |
| Feb 21, 2024 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 125,000 | n/a |
| Jun 15, 2023 | Vanda Pharmaceuticals Inc. (VNDA) | Sale | 14,600 | $95.8K |
| Mar 6, 2023 | Vanda Pharmaceuticals Inc. (VNDA) | Sale | 8,437 | $52.7K |
| Feb 21, 2023 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 32,700 | n/a |